This event has passed.
CPhI Worldwide
This event has passed.
CPhI Worldwide
Register here
about the Event
In 2022, CPhI Worldwide will become CPHI Frankfurt: a 3-day event that will take place in person and online.
In addition to the dates in Frankfurt, this format will see our event take place online over an extended period of time, allowing you the flexibility to connect, network, learn and do business – when and how it suits you.
See who is attending from Bachem - Booth #121A60
Please join our colleagues on booth 121A60:
Pascall Hess
Sergey Malashikhin
Georgios Georgopoulos
Joachim Wimmer
Eric Bouillet
Andre Casagrande
Franziska Arnhold
Philippe Theron
Gary Hu
Bachem presentations
Bachem Breakfast Session on November 2nd, 9:30am
WHY IS INNOVATION KEY FOR GENERICS?
Start your day with Bachem, breakfast and networking in-person at CPHI Frankfurt and explore why innovation is so key for generics.
There is more to creating generic peptide APIs than simply following a recipe. How you make them makes a difference. Large-scale manufacturing of these substances involves many challenges; from decreasing yields for longer peptides, to the enormous amounts of solvents needed for purification.
The only way to produce these drug substances efficiently, sustainably and in the highest quality is by optimizing the manufacturing process using innovative technologies. In this breakfast session, featuring an exciting expert keynote presentation and interactive Q&A, learn why innovation is key for manufacturing these APIs, and how Bachem drives technical developments to guarantee the best API supply for our clients.
PLEASE REGISTER FOR FREE:
Bachem CPHI Breakfast and Content Session
Speaker
Torsten Wöhr, PhD
Chief Marketing Officer (CMO)
Torsten Wöhr joined Bachem in 2017 as Sales Director for the generic API business and has led Bachem’s oligonucleotide program since 2019. Previously he held commercial leadership roles in various pharmaceutical manufacturing and life sciences companies in the United States and Europe. He studied biochemistry & molecular biology at the Swiss Federal Institute of Technology (ETH) Zurich and holds a doctorate in bioorganic chemistry from the University of Lausanne/EPFL and a postgraduate degree in Industrial Engineering and Management, ETH Zurich.
Kira Mournier
Associate Sales Manager Generics
Kira Isabelle Mounier is a certified pharmacist, who worked in a consulting company for local start-ups in the Basel area before joining Bachem as Associate Sales Manager Generics
and Business Development with focus on development projects in May 2021.
Moderator
Manuela Schneider, PhD
Vice President, Head Global Marketing
In 2020, Manuela joined Bachem as Vice President Global Marketing based in Bubendorf. She holds a PhD in Biochemistry.
Prior to Bachem, Manuela worked more than 20 years in roles with increasingresponsibility for Pfizer, Novartis, Novo Nordisk, Vifor-Fresenius and GC Aesthetics, during the last 10 years at Vice President- or C-level. With herbroad marketing and leadership experience she puts a strong focus on market intelligence, customer centricity and digital marketing.
Tony Molloy
Customer Experience Expert
Bachem presentation on November 2nd, 3pm
Sustainable production of complex API
Improving the sustainability in the CDMO industry is a multi-facetted approach covering environmental, economic and social tasks while having a strong focus on these areas where a company can make the highest impact. Bachem, the leading manufacturer of peptides and oligonucleotides is a good example for using this approach successfully. By innovating for better manufacturing the company could massively reduce greenhouse gas emissions and solvent consumptions: something that is also of utmost interest when searching for a partner for large-scale production of oligonucleotides and peptides.
Speaker
Tycho Leifels, PhD
Group Leader Product Management
Tycho Leifels is an experienced life science portfolio professional with a successful record of leading business development and pipeline strategy. His broad expertise is based on 17 years in various commercial roles with increasing responsibilities in the life science industry including successful international product launches and managing the portfolio towards higher profitability. He holds a PhD in chemistry from the University of Basel.